• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: COOK INC ADVANCE 35 LP LOW PROFILE BALLOON CATHETER; LIT CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

COOK INC ADVANCE 35 LP LOW PROFILE BALLOON CATHETER; LIT CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL Back to Search Results
Model Number G35532
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 09/17/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Occupation: rt.This report includes information known at this time.A follow-up report will be submitted should additional relevant information become available.
 
Event or Problem Description
As reported, during a percutaneous transluminal angioplasty of an 80% occluded lesion, within the left proximal-to-mid superficial femoral artery, an advance 35 lp low profile balloon catheter ruptured upon the first inflation.The proximal portion of the balloon ruptured circumferentially at ten atmospheres.The device was removed from the patient by itself and the user attempted to inflate the device again, when contrast was found to leak from the balloon.A 6 french cook ansel sheath and cook inflation device were used during the procedure.The anatomy was slightly calcified; however, angulation and tortuosity were not observed.Blood was noted in the inflation device at the time of rupture.The device was not inflated within a stent.A different balloon was used to complete the procedure.A section of the device did not remain inside the patient¿s body.The patient did not require any additional procedures due to this occurrence.According to the initial reporter, the patient did not experience any adverse effects due to this occurrence.
 
Additional Manufacturer Narrative
Description of event: as reported, during a percutaneous transluminal angioplasty of an 80% occluded lesion, within the left proximal-to-mid superficial femoral artery, an advance 35 lp low profile balloon catheter ruptured upon the first inflation.The proximal portion of the balloon ruptured circumferentially at ten atmospheres.The device was removed from the patient by itself and the user attempted to inflate the device again, when contrast was found to leak from the balloon.A 6 french cook ansel sheath and cook inflation device were used during the procedure.The anatomy was slightly calcified; however, angulation and tortuosity were not observed.Blood was noted in the inflation device at the time of rupture.The device was not inflated within a stent.A different balloon was used to complete the procedure.Investigation ¿ evaluation: a visual inspection and functional testing of the returned device was conducted.A document based investigation was also performed including a review of complaint history, device history record, documentation, drawings, the instructions for use, manufacturing instructions, quality control data, and specifications.The complainant returned one pta5 balloon catheter to cook for investigation.Biomatter was present on the returned device.Biomatter and blood were present in the balloon.The balloon was squeezed and when squeezed blood did not come out of the balloon.The balloon was unable to be inflated.The balloon was decontaminated for 3 days.Additional dfa performed on 02oct2020.The balloon was re-inflated to find pinhole leak at the proximal end.Therefore, the balloon did not rupture circumferntially as initially reported, device failure analysis confirmed balloon had a pinhole leak rupture.A review of the device history record found no non-conformances related to the reported failure mode.Because there are no related non-conformances, adequate inspection activities have been established, there is objective evidence that the dhr was fully executed, and no other lot related complaints that have been received from the field, it was concluded that there is no evidence that nonconforming product exists in house or in field.A review of complaint history records shows no other complaints associated with the complaint device lot.The instructions for use (ifu), provides the following information to the user related to the reported failure mode: device description ¿the balloon is manufactured from an extra-thinwall, high-strength, minimally compliant material.Particular care should be taken in handling the balloon to prevent damage.It will inflate to the indicated size parameters when utilizing proper pressure recommendations.Adhere to balloon inflation pressure parameters indicated in the compliance card insert.Refer to label for further information.Use of a pressure gauge is recommended to monitor inflation pressures.¿ intended use: ¿the advance 35lp low profile pta balloon dilatation catheter is indicated for percutaneous transluminal angioplasty (pta) of lesions peripheral arteries including iliac, renal, popliteal, infrapopliteal, femoral, and iliofemoral as well as obstructive lesions of native or synthetic arteriovenous dialysis fistulae.¿ warnings: ¿do not exceed rated burst pressure.Rupture of balloon may occur.Adhere to balloon inflation pressure parameters in the compliance card insert.Over-inflation may cause rupture of the balloon, which resultant damage to the vessel wall.Use of a pressure gauge is recommended to monitor inflation pressures.¿ ¿do not use a power injector for balloon inflation or injection of contrast medium through catheter lumen marked ¿distal¿.Rupture may occur.¿ precautions: ¿the catheter is not intended for the delivery of stents.¿ ¿all stents should be deployed in accordance with the manufacturer¿s indications and instructions for use.¿ instructions for use: balloon preparation ¿choose a balloon appropriate to lesion length and vessel diameter.¿ ¿upon removal from package, inspect the catheter to ensure no damage has occurred during shipping.¿ balloon introduction and inflation: ¿note: if resistance is met while advancing the balloon dilatation catheter, determine the cause and proceed with caution.¿ ¿inflate balloon to desired pressure.Adhere to recommended balloon inflation pressures.(see compliance card insert.)¿ ¿if balloon pressure is lost and/or balloon rupture occurs, deflate balloon and remove balloon and sheath as a unit.¿ how supplied: ¿store in a dark, dry, cool place.Avoid extended exposure to light.Upon removal from package, inspect the product to ensure no damage has occurred.¿ a review of relevant manufacturing documents was conducted.It was concluded that the device aspect in question was visually/functionally inspected by quality control and no related gaps in production or processing controls were noted.Cook has concluded that a definitive conclusion could not be determined.Per the quality engineering risk assessment, no further action is warranted.Cook will continue to monitor this device via the complaints database for similar complaints.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned; that a death or serious injury occurred; or that any cook device caused or contributed to; or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
 
Event or Problem Description
No new patient or event information to report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVANCE 35 LP LOW PROFILE BALLOON CATHETER
Common Device Name
LIT CATHETER, ANGIOPLASTY, PERIPHERAL, TRANSLUMINAL
Manufacturer (Section D)
COOK INC
750 daniels way
bloomington IN 47404
MDR Report Key10570211
Report Number1820334-2020-01730
Device Sequence Number2562227
Product Code LIT
UDI-Device Identifier10827002355320
UDI-Public(01)10827002355320(17)230414(10)13131504
Combination Product (Y/N)N
Initial Reporter StateIN
Initial Reporter CountryUS
PMA/510(K) Number
K132020
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 02/04/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date04/14/2023
Device Model NumberG35532
Device Catalogue NumberPTA5-35-135-5-20.0
Device Lot Number13131504
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/29/2021
Initial Date Received by Manufacturer 09/17/2020
Supplement Date Received by Manufacturer01/22/2021
Initial Report FDA Received Date09/22/2020
Supplement Report FDA Received Date02/04/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
-
-